{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:10:42Z","timestamp":1772071842393,"version":"3.50.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00347-021-01468-4","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T15:02:52Z","timestamp":1636038172000},"page":"1091-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Akuter retinaler Zentralarterienverschluss","Acute central retinal artery occlusion"],"prefix":"10.1007","volume":"118","author":[{"given":"Maximilian","family":"Schultheiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0576-y","author":"M Fallico","year":"2019","unstructured":"Fallico\u00a0M, Lotery\u00a0AJ, Longo\u00a0A et al (2019) Risk of acute stroke in patients with retinal artery occlusion: a\u00a0systematic review and meta-analysis. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-019-0576-y","journal-title":"Eye (Lond)"},{"issue":"10","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.ophtha.2018.03.054","volume":"125","author":"V Biousse","year":"2018","unstructured":"Biousse\u00a0V, Nahab\u00a0F, Newman\u00a0NJ (2018) Management of acute retinal ischemia: follow the guidelines! Ophthalmology 125(10):1597\u20131607","journal-title":"Ophthalmology"},{"issue":"10266","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","volume":"396","author":"IU Scott","year":"2020","unstructured":"Scott\u00a0IU, Campochiaro\u00a0PA, Newman\u00a0NJ, Biousse\u00a0V (2020) Retinal vascular occlusions. Lancet 396(10266):1927\u20131940","journal-title":"Lancet"},{"issue":"7","key":"1468_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","volume":"51","author":"MB Grory","year":"2020","unstructured":"Grory\u00a0MB, Nackenoff\u00a0A, Poli\u00a0S et al (2020) Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke 51(7):2018\u20132025","journal-title":"Stroke"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01468-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T15:05:46Z","timestamp":1636038346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01468-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01468-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"7 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Schultheiss, S.\u00a0Poli und M.S.\u00a0Spitzer sind die Initiatoren der REVISION-Studie (ClinicalTrials.gov Identifier: NCT04965038). Zudem unterst\u00fctzt Boehringer-Ingelheim Pharma GmbH & Co. KG die REVISION-Studie durch die Bereitstellung der Studienmedikation (Verum und Placebo).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}